Undecylenic Acid: The FDA-Recognized Antifungal Active, Explained

An FDA OTC monograph is a formal regulatory category built on an ingredient's own safety and efficacy data, reviewed by the agency: a real, checkable status, not a brand's self-description. It means the FDA has determined that undecylenic acid, formulated within a specified concentration range, is generally recognized as safe and effective for its stated topical antifungal use. That's a meaningfully stronger evidence bar than most ingredients marketed in the natural-supplement space clear, and it's the primary reason undecylenic acid earns the strongest single evidence rating among Kerassentials' 8 named ingredients.

Monograph recognition applies to undecylenic acid at specific, disclosed concentrations, typically 10-25% in products that carry this designation formally. A product that names "undecylenic acid" on its ingredient list without stating a concentration cannot claim the benefit of that monograph status in any meaningful, checkable way, because the entire basis for FDA recognition is dose-dependent. A competing product in this category, Funginix, discloses its concentration at 10%, neither Kerassentials nor ProNail Complex discloses a concentration for any of their named ingredients, including undecylenic acid, which is why our reviews treat this as a real, checkable transparency gap rather than crediting either product with the ingredient's full regulatory weight.

Undecylenic acid is genuinely the best-evidenced named ingredient in both Kerassentials' and ProNail Complex's formulas: real FDA OTC monograph recognition, not a vague "natural antifungal" claim. But that recognition is tied to specific, disclosed concentrations that neither product publishes. See our full Kerassentials review and ProNail Complex review for the complete Trust Score reasoning: a real regulatory-grade active ingredient, undermined by the same undisclosed-concentration gap that limits both formulas.